NAVIGNOSTICS Trademark
NAVIGNOSTICS is a USPTO trademark filed by Navignostics AG. Status: Registered.
Trademark Facts
| Mark | NAVIGNOSTICS |
|---|---|
| Serial Number | 79395780 |
| Registration Number | 7862453 |
| Status | Registered |
| Filing Date | 2024-02-15 |
| Registration Date | 2025-07-15 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT) |
| Owner | Navignostics AG |
| Attorney of Record | Nicholas D. Wells |
| Prosecution Events | 26 |
| Latest Event | FINO on 2026-04-02 |
Goods & Services
Reactants for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical or veterinary use in in vitro diagnosis; reactants for medical diagnosis, particularly for usage with spatial single-cell proteomics reagents for diagnostic tests for medical use; diagnostic test reagents for veterinary use; diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations for medical purposes; diagnostic substances for medical use; pharmaceutical products, medical and veterinary preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical preparations for the diagnosis of diseases; diagnostic pharmaceutical preparations; pharmaceutical preparations for individual medical diagnosis; medical test kits comprising pharmaceutical preparations for cancer therapy; medical test kits comprising pharmaceutical preparations for use in oncology for cancer screening; medical test kits comprising pharmaceutical preparations for cancer diagnosis; medical test kits comprising pharmaceutical preparations for individual medical diagnosis in the field of protein imaging; diagnostic test kits comprising pathology slides for testing tissue samples; test kits for use in oncology comprising sample tubes for testing tissue samples; diagnostic test kits comprising laboratory equipment for sample preparation, processing and storage for cancer diagnosis; diagnostic test kits for individual medical diagnosis comprising sample collection equipment for tumour analysis; Apparatus for tumour diagnosis, namely, Imaging Mass Cytometry (IMC) apparatus; medical apparatus, namely, spectrometers for machine learning-based spectrum analysis of human blood plasma; Multiplex protein imaging scanners for medical diagnosis; apparatus for clinical diagnosis, namely, digital imaging device; spectrum analysers for use in medical diagnosis; trace material analysers for medical use in diagnosis; apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins, namely, spatial proteomics tools; medical test kits for cancer testing; diagnostic, examination, and monitoring equipment, namely, multiplex protein imaging equipment; medical test kits comprising tissue sampling equipment for the use in oncology for cancer screening; medical test kits for cancer diagnosis; medical test kits comprising tissue analysis tools for individual diagnosis in the field of cancer therapy; Scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of proteomics; oncological research; medical research in the field of oncological diagnostics; computer programming for medical data analysis for cancer diagnostics; development of personalized diagnostics products in the nature of data sampling, imaging and analysis for cancer treatment; software-as-a-service (SaaS) featuring software for use in cancer diagnosis; platform-as-a-service (PaaS) featuring software for use in cancer diagnosis; software-as-a-service (SaaS) featuring software for cell analysis for use in oncology; platform-as-a-service (PaaS) featuring software for cell analysis for use in oncology; software-as-a-service (SaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; platform-as-a-service (PaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; software-as-a-service (SaaS) featuring software using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; platform-as-a-service (PaaS) featuring software using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; computer programming in the field of using machine learning regarding medical diagnosis and research, particularly for cancer research, treatment and diagnosis; software as a service (SaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software-as-a-service (SaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; platform-as-a-service (PaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software as-a-service (SaaS) featuring software for the digital representation of tumours and tumour features; platform-as-a-service (PaaS) featuring software for the digital representation of tumours and tumour features; software as-a-service (SaaS) featuring software for high-resolution digital image representation of the molecular composition of cellular anomalies; platform-as-a-service (PaaS) featuring software for high-resolution digital image representation of the molecular composition of cellular anomalies; software as-a-service (SaaS) featuring software for high-resolution digital image representation of digital tumours; platform-as-a-service (PaaS) featuring software for high-resolution digital image representation of digital tumours; cancer diagnosis research